Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Sarcoma 1

Conditions

Uterine Cervical Neoplasms 15Prostatic Neoplasms 13Neoplasms 4Breast Neoplasms 4Vaginal Neoplasms 2Uterine Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Endometrial Clear Cell Adenocarcinoma 2Vulvar Neoplasms 1Stage IA Uterine Sarcoma 1Radiation Injuries 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Obesity 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Lung Neoplasms 1Locally Advanced Cervical Cancer 1Liver Neoplasms 1Fatigue 1Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1Endometrial Adenocarcinoma 1Desmoplastic Small Round Cell Tumor 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Breast Carcinoma In Situ 1Biliary Tract Neoplasms 1

Interventions

Brachytherapy 2Taxes 1Standard of Care 1Radiotherapy 1Radiation 1Practice Guidelines as Topic 1Platinum 1Paclitaxel 1Cisplatin 1Carboplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Endometrial Clear Cell Adenocarcinoma × Brachytherapy × Clear all
NCT03422198 2025-12-12

SAVE

University of Utah

Phase 3 Recruiting
188 enrolled 15 charts
GynecologicSarcoma

Endometrial Clear Cell Adenocarcinoma

NCT00942357 2021-10-19

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

GOG Foundation

Phase 3 Unknown
813 enrolled 14 charts
Gynecologic

Endometrial Clear Cell Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡